Time to scale up testing and treatment for HBV and HCV in the WHO Eastern Mediterranean Region

Lancet Gastroenterol Hepatol. 2023 Oct;8(10):868-870. doi: 10.1016/S2468-1253(23)00239-X. Epub 2023 Jul 26.

Authors

Ahmed Sabry Alaama¹, Capucine Pénicaud², Oriel Fernandes³, Muhammad S Jamil⁴, Joumana Hermez⁴, Yvan J-F Hutin⁴

Affiliations

¹ Universal Health Coverage: Department of Communicable Disease Prevention and Control, WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt. Electronic address: sabrya@who.int.
² The Hepatitis Fund, Geneva, Switzerland.
³ Clinton Health Access Initiative, Boston, MA, USA.
⁴ Universal Health Coverage: Department of Communicable Disease Prevention and Control, WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt.

PMID: 37516127
DOI: 10.1016/S2468-1253(23)00239-X

No abstract available

MeSH terms

Hepatitis B virus*
Hepatitis C* / diagnosis
Hepatitis C* / drug therapy
Hepatitis C* / epidemiology
Humans
Mediterranean Region / epidemiology
Risk Factors
World Health Organization

Grants and funding

001/WHO_/World Health Organization/International